Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
PF-07238025
Cat. No.:
OB0425LY-409
Appearance:
Solid
Purity:
99.46%
Identity:
Confirmed by NMR, HPLC, and LC-MS.
Size:
Add to basket
Product Overview
Description:
PF-07238025 is a selective inhibitor of a specific enzyme pathway related to metabolic diseases, that stabilizes the interaction between BDK and BCKDH core subunit E2 and prevents phosphorylation of E.
Synonyms:
PF-07238025; PF07238025; PF 07238025
Formula:
C19H18N2O3S
Formula Weight:
354.42
Specification
Target:
Endogenous metabolite
Pathway:
Metabolic enzyme/Protease
Solubility:
DMSO
Storage:
Storage at -20°C.
Applications:
PF-07238025 can be used in studies of the regulation of metabolic processes in diseases such as obesity and diabetes.
